Computational Molecular Biology 2025, Vol.15, No.3, 131-140 http://bioscipublisher.com/index.php/cmb 138 Conflict of Interest Disclosure The authors affirm that this research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest. References Angulo-Aguado M., Panche K., Tamayo-Agudelo C., Ruiz-Torres D., Sambracos-Parrado S., Niño-Orrego M., Páez N., Piñeros-Hernandez L., Castillo-León L., Pardo-Oviedo J., Abaunza K., Laissue P., Contreras N., Calderón-Ospina C., and Fonseca-Mendoza D., 2021, A pharmacogenetic study of CYP2C19 in acute coronary syndrome patients of Colombian origin reveals new polymorphisms potentially related to clopidogrel therapy, Journal of Personalized Medicine, 11(5): 400. https://doi.org/10.3390/jpm11050400 Baek S., Jeong Y., Kim Y., Kim J., Kim J., Kim E., Lim J., Kim J., Kim Z., Kim K., and Chung M., 2024, Development and validation of a robust and interpretable early triaging support system for patients hospitalized with COVID-19: predictive algorithm modeling and interpretation study, Journal of Medical Internet Research, 26: e52134. https://doi.org/10.2196/52134 Calvino G., Peconi C., Strafella C., Trastulli G., Megalizzi D., Andreucci S., Cascella R., Caltagirone C., Zampatti S., and Giardina E., 2024, Federated learning: breaking down barriers in global genomic research, Genes, 15(12): 1650. https://doi.org/10.3390/genes15121650 Chandrashekar R., Dasari K., Mishra M., Nijhawan G., Kalra R., and Abood B., 2024, Distributed bioengineering data analysis preserving privacy with federated learning, In: 2024 OPJU International Technology Conference (OTCON) on Smart Computing for Innovation and Advancement in Industry 4.0, IEEE, pp.1-6. https://doi.org/10.1109/OTCON60325.2024.10687990 Cheng C., Zhao Y., Schaafsma E., Weng Y., and Amos C., 2020, An EGFR signature predicts cell line and patient sensitivity to multiple tyrosine kinase inhibitors, International Journal of Cancer, 147(9): 2621-2633. https://doi.org/10.1002/ijc.33053 Clayton E., Pujol T., McDonald J., and Qiu P., 2020, Leveraging TCGA gene expression data to build predictive models for cancer drug response, BMC Bioinformatics, 21(Suppl 14): 364. https://doi.org/10.1186/s12859-020-03690-4 Creighton C., 2013, Widespread molecular patterns associated with drug sensitivity in breast cancer cell lines, with implications for human tumors, PLoS ONE, 8(12): e71158. https://doi.org/10.1371/journal.pone.0071158 Fortuin S., and Soares N., 2022, The integration of proteomics and metabolomics data paving the way for a better understanding of the mechanisms underlying microbial acquired drug resistance, Frontiers in Medicine, 9: 849838. https://doi.org/10.3389/fmed.2022.849838 Guang M., McCann A., Bianchi G., Zhang L., Dowling P., Bazou D., O’Gorman P., and Anderson K., 2018, Overcoming multiple myeloma drug resistance in the era of cancer ‘omics’, Leukemia & Lymphoma, 59(3): 542-561. https://doi.org/10.1080/10428194.2017.1337115 Hu Y., Zhao L., Li Z., Dong X., Xu T., and Zhao Y., 2022, Classifying the multi-omics data of gastric cancer using a deep feature selection method, Expert Systems with Applications, 200: 116813. https://doi.org/10.1016/j.eswa.2022.116813 Huang C., Huang Y., Shen S., Liu C., Yang C., and Kuo C., 2018, Factors predicting the efficacy of osimertinib in T790M-mutated metastatic lung adenocarcinoma, Respirology, 23(S2): 20. https://doi.org/10.1111/resp.13419_43 Jung H., Sung Y., and Kim H., 2021, Omics and computational modeling approaches for the effective treatment of drug-resistant cancer cells, Frontiers in Genetics, 12: 742902. https://doi.org/10.3389/fgene.2021.742902 Lee C., Luzum J., Sangkuhl K., Gammal R., Sabatine M., Stein C., Kisor D., Limdi N., Lee Y., Scott S., Hulot J., Roden D., Gaedigk A., Caudle K., Klein T., Johnson J., and Shuldiner A., 2022, Clinical Pharmacogenetics Implementation Consortium guideline for CYP2C19 genotype and clopidogrel therapy: 2022 update, Clinical Pharmacology & Therapeutics, 112(5): 959-967. https://doi.org/10.1002/cpt.2526 Li J., Chen Z., Sun D., Xu M., Zhang X., and Xu J., 2010, The quantitative analysis of epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) and its correlation with response rate of EGFR tyrosine kinase inhibitors (TKI), Clinical Cancer Research, 16(19_Supplement): PR10. https://doi.org/10.1158/DIAG-10-PR10 Liu X., and Mei X., 2023, Prediction of drug sensitivity based on multi-omics data using deep learning and similarity network fusion approaches, Frontiers in Bioengineering and Biotechnology, 11: 1156372. https://doi.org/10.3389/fbioe.2023.1156372 Liu Z., and Park T., 2024, DMOIT: denoised multi-omics integration approach based on transformer multi-head self-attention mechanism, Frontiers in Genetics, 15: 1488683. https://doi.org/10.3389/fgene.2024.1488683
RkJQdWJsaXNoZXIy MjQ4ODYzNA==